A first look at the phase 3 data with Eli Lilly's oral GLP-1 agonist orforglipron reveals encouraging blood sugar control data in patients with type 2 diabetes, and a side-effect profile free of the ...

April 6, 2026 • Higher education is especially reliant on computers and phones, but accessibility for people with disabilities has often been forgotten. A new federal rule could change that. February ...